SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-03-011139
Filing Date
2003-03-31
Accepted
2003-03-31 12:26:54
Documents
5
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2107101z10-k.htm 10-K 554881
3 EXHIBIT 21.1 a2107101zex-21_1.htm EX-21.1 2204
4 EXHIBIT 23.1 a2107101zex-23_1.htm EX-23.1 2257
5 EXHIBIT 99.1 a2107101zex-99_1.htm EX-99.1 2593
6 EXHIBIT 99.2 a2107101zex-99_2.htm EX-99.2 979
  Complete submission text file 0001047469-03-011139.txt   564783
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21481 | Film No.: 03628455
SIC: 2836 Biological Products, (No Diagnostic Substances)